Ensuring Integrity in Clinical Supply Chains: Direct-to-Patient GDP Logistics in Hong Kong

Maintaining strict temperature control and precise time windows in clinical trials is far more than a logistics exercise—it is fundamental to patient safety and the integrity of the study itself. Any deviation can compromise product quality, delay dosing, or impact trial data, making reliable, GDP-compliant execution essential.

NAF Pharma Logistics recently managed a critical Direct-to-Patient (DTP) delivery of a study drug requiring continuous controlled ambient temperature monitoring between +15°C and +25°C. The shipment demanded end-to-end visibility, validated packaging, and exact timing to protect both the product and the patient experience.

How we executed this seamless shipment:

• Pick-up: Direct collection from the Clinical Research Pharmacy at Prince of Wales Hospital (PWH), ensuring chain-of-custody integrity from the point of origin.
• Thermal Protection: Validated passive thermal packaging combined with calibrated real-time and downloadable data loggers provided continuous temperature monitoring and full compliance documentation throughout the journey.
• Delivery: On-time Direct-to-Patient delivery within a strictly defined time window, balancing patient convenience with protocol adherence and regulatory requirements.

This successful DTP operation reflects NAF’s broader capability to support both local clinical sites and more complex cold-chain requirements across Asia. Whether the need is ambient controlled transport, specialized packaging, real-time monitoring, or coordinated last-mile delivery, our team focuses on compliant, reliable, and patient-centric solutions that protect product quality and trial timelines.

Looking to strengthen the integrity and efficiency of your clinical trial supply chain? Contact our team today to discuss how our specialized Direct-to-Patient capabilities can support your next study.